Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort
MAbs real-world data over a 2-year changing pandemic landscape showed the feasibility of the intervention, although the hospitalization rate was not negligible. Immunosuppressed subjects remain more at risk of clinical worsening.
Authors
- Alban Rugova
- Francesca Bai (ORCID: https://orcid.org/0000-0002-3651-8923)
- Maurizio Milesi
- Simone Vasilij Benatti (ORCID: https://orcid.org/0000-0003-2807-3618)
- Filippo Chiabrando (ORCID: https://orcid.org/0009-0004-3680-7559)
- Francesca Graziano (ORCID: https://orcid.org/0000-0003-1825-3527)
- Marco Rizzi (ORCID: https://orcid.org/0000-0003-0445-9655)
- Anna Cappelletti
- Eugenia Quirós-Roldán (ORCID: https://orcid.org/0000-0003-1452-9100)
- Alessandro Soria (ORCID: https://orcid.org/0000-0002-4447-2574)
- Stefania Galimberti (ORCID: https://orcid.org/0000-0003-1504-7242)
- Paola Morelli (ORCID: https://orcid.org/0000-0001-9555-5284)
- Davide Minisci
- Doménico Lombardi (ORCID: https://orcid.org/0000-0003-4116-8347)
- Stefano Rusconi (ORCID: https://orcid.org/0000-0002-0375-9990)
- Nicola Squillace (ORCID: https://orcid.org/0000-0002-7608-6045)
- Emanuela Rossi (ORCID: https://orcid.org/0000-0002-3431-7618)
- Daniela Dalla Gasperina (ORCID: https://orcid.org/0000-0002-1187-6222)
- Luigi Pusterla
- Francesco Castelli (ORCID: https://orcid.org/0000-0001-9161-7804)
- Maria Lucia Borghesi
- Giulia Irene Ghilardi
- Erika Asperges (ORCID: https://orcid.org/0000-0002-1618-8867)
- Giovanna Travi (ORCID: https://orcid.org/0000-0002-4206-0066)
- Raffaele Bruno (ORCID: https://orcid.org/0000-0002-0235-9207)
- Marco Franzetti (ORCID: https://orcid.org/0000-0002-6203-7584)
- Marco Merli (ORCID: https://orcid.org/0000-0001-5081-8669)
- Daria Pocaterra
- Fabio Franzetti
- Paolo Bonfanti (ORCID: https://orcid.org/0000-0001-7289-8823)
- Stefania Piconi (ORCID: https://orcid.org/0000-0001-7058-1048)
- Alessandro Pandolfo
- Giuseppe Lapadula (ORCID: https://orcid.org/0000-0002-9976-8102)
- Patrizia Rovere‐Querini (ORCID: https://orcid.org/0000-0003-2615-3649)
- Angelo Pan (ORCID: https://orcid.org/0000-0003-2340-4916)
- Alessandra Bandera (ORCID: https://orcid.org/0000-0003-1626-0328)
- Antonella D'Arminio Monforte
- Francesco Dentali (ORCID: https://orcid.org/0000-0001-8266-5134)
- Fabio Zanini
- Giulia Marchetti
- Salvatore Casari
- M Mallardo
- Maria Grazia Valsecchi
Institutions
- University of Insubria (IT)
- AOL (United States) (US)
- Vita-Salute San Raffaele University (IT)
- University of Milan (IT)
- University of Pavia (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- Ospedale Papa Giovanni XXIII (IT)
- Azienda Ospedaliera San Gerardo (IT)
- Alessandro Manzoni Hospital (IT)
- Ospedale di Circolo di Busto Arsizio (IT)
- Azienda Socio Sanitaria Territoriale Lariana (IT)
- IRCCS Ospedale San Raffaele (IT)
- Ospedale Bassini (IT)
- Music Conservatory of Mantova (IT)
- Policlinico San Matteo Fondazione (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- American Association for the Surgery of Trauma (US)
- Azienda Ospedaliera Ospedale Civile di Legnano (IT)
- IRCCS Humanitas Research Hospital (IT)
- Chemi (Italy) (IT)
- Azienda Ospedaliera Carlo Poma (IT)
- Istituti Ospitalieri di Cremona (IT)
- University of Milano-Bicocca (IT)
- University of Brescia (IT)
Publication Details
- Journal
- Heliyon
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e36102
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39